Ekocorp

Ekocorp Net Change in Cash

The Net Change in Cash of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is -20.98 M NGN. In the previous year, Net Change in Cash was -20.98 M NGN — a change of 0.00% (lower).

Net Change in Cash

-20.98 MNGN

YoY

0.00%

Last updated:

Net Change in Cash of Ekocorp is 2020 -20.98 M NGN. Net Change in Cash of Ekocorp was 2019 -20.98 M NGN. It decreases by 0.00% lower compared to the previous year.

The Ekocorp Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2015
-691,600.00 NGN
Jan 1, 2016
45.39 M NGN
Jan 1, 2017
-63.51 M NGN
Jan 1, 2018
8.38 M NGN
Jan 1, 2019
-20.98 M NGN
Jan 1, 2020
-20.98 M NGN
The Ekocorp Net Change in Cash history
YEARNet Change in CashYoY
-20.98 MNGN0.00%
-20.98 MNGN-350.46%
8.38 MNGN-113.19%
-63.51 MNGN-239.94%
45.39 MNGN-6,662.32%
-691,600.00NGN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

Net Change in Cash of Ekocorp is -20.98 M NGN in 2020.

Net Change in Cash of Ekocorp changed from -20.98 M NGN to -20.98 M NGN, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Ekocorp since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's NGN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Ekocorp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ekocorp

All Key Metrics — Ekocorp